Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.855,17
-0,04%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Standard BioTools Inc (LAB) Standard BioTools Inc (LAB) Notizie

LAB

Standard BioTools (LAB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LAB
DataOraFonteTitoloSimboloCompagnia
25/04/202414:01GlobeNewswire Inc.Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthNASDAQ:LABStandard BioTools Inc
25/04/202414:00GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024NASDAQ:LABStandard BioTools Inc
08/04/202414:00GlobeNewswire Inc.Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue ImagingNASDAQ:LABStandard BioTools Inc
03/04/202422:01GlobeNewswire Inc.Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine ResearchNASDAQ:LABStandard BioTools Inc
18/03/202413:12GlobeNewswire Inc.Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common StockNASDAQ:LABStandard BioTools Inc
07/03/202401:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
28/02/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
28/02/202422:01GlobeNewswire Inc.Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LABStandard BioTools Inc
26/02/202422:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LABStandard BioTools Inc
26/02/202414:00GlobeNewswire Inc.Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen SequencingNASDAQ:LABStandard BioTools Inc
22/02/202422:05GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
14/02/202421:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LABStandard BioTools Inc
14/02/202414:30GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:LABStandard BioTools Inc
08/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LABStandard BioTools Inc
07/02/202414:30GlobeNewswire Inc.Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized MedicineNASDAQ:LABStandard BioTools Inc
02/02/202422:49Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LABStandard BioTools Inc
19/01/202423:07Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LABStandard BioTools Inc
19/01/202423:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LABStandard BioTools Inc
19/01/202422:33Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:LABStandard BioTools Inc
12/01/202420:04Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LABStandard BioTools Inc
10/01/202400:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
08/01/202414:30GlobeNewswire Inc.Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 RevenueNASDAQ:LABStandard BioTools Inc
05/01/202414:46GlobeNewswire Inc.Standard BioTools Completes Merger with SomaLogic, Creating a Diversified and Scaled Leader in Life Sciences ToolsNASDAQ:LABStandard BioTools Inc
05/01/202404:23GlobeNewswire Inc.Standard BioTools Stockholders Approve Merger with SomaLogicNASDAQ:LABStandard BioTools Inc
05/01/202403:44PR Newswire (US)SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special MeetingNASDAQ:LABStandard BioTools Inc
29/12/202323:26Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:LABStandard BioTools Inc
29/12/202323:04GlobeNewswire Inc.Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogicNASDAQ:LABStandard BioTools Inc
28/12/202322:16PR Newswire (US)Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioToolsNASDAQ:LABStandard BioTools Inc
26/12/202321:59PR Newswire (US)SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading DisclosureNASDAQ:LABStandard BioTools Inc
23/12/202300:57GlobeNewswire Inc.ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogicNASDAQ:LABStandard BioTools Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:LAB

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network